Bcl-2 is a key regulator for the retinoic acid-induced apoptotic cell death in neuroblastoma

[1]  C. Culmsee,et al.  p53 in neuronal apoptosis. , 2005, Biochemical and biophysical research communications.

[2]  S. Korsmeyer,et al.  An inhibitor of Bcl-2 family proteins induces regression of solid tumours , 2005, Nature.

[3]  S. Nilsson,et al.  Imbalance of the mitochondrial pro- and anti-apoptotic mediators in neuroblastoma tumours with unfavourable biology. , 2005, European journal of cancer.

[4]  Ming-tao Li,et al.  Activity deprivation-dependent induction of the proapoptotic BH3-only protein Bim is independent of JNK/c-Jun activation during apoptosis in cerebellar granule neurons , 2005, Neuroscience Letters.

[5]  K. Tanabe,et al.  Therapeutic potential of antisense Bcl‐2 as a chemosensitizer for cancer therapy , 2004, Cancer.

[6]  H. Osaka,et al.  Retinoic Acid Induces Neuroblastoma Cell Death by Inhibiting Proteasomal Degradation of Retinoic Acid Receptor α , 2004, Cancer Research.

[7]  A. Saito,et al.  The c-Jun N-Terminal Protein Kinase Signaling Pathway Mediates Bax Activation and Subsequent Neuronal Apoptosis through Interaction with Bim after Transient Focal Cerebral Ischemia , 2004, The Journal of Neuroscience.

[8]  R. Versteeg,et al.  Pediatric neuroblastomas: genetic and epigenetic 'danse macabre'. , 2004, Gene.

[9]  N. Schor,et al.  Neuroblastoma as a Neurobiological Disease , 2004, Journal of Neuro-Oncology.

[10]  R. Knight,et al.  Retinoids and the control of growth/death decisions in human neuroblastoma cell lines , 2004, Journal of Neuro-Oncology.

[11]  Suzanne Cory,et al.  The Bcl-2 family: roles in cell survival and oncogenesis , 2003, Oncogene.

[12]  Alexei Degterev,et al.  A decade of caspases , 2003, Oncogene.

[13]  J. Herman,et al.  Clustering of hypermethylated genes in neuroblastoma , 2003, Genes, chromosomes & cancer.

[14]  E. Dmitrovsky,et al.  Retinoids in cancer therapy and chemoprevention: promise meets resistance , 2003, Oncogene.

[15]  M. Maden,et al.  Too much of a good thing: retinoic acid as an endogenous regulator of neural differentiation and exogenous teratogen , 2003, The European journal of neuroscience.

[16]  Yohko Nakamura,et al.  Accumulation of p27KIP1 is associated with BMP2-induced growth arrest and neuronal differentiation of human neuroblastoma-derived cell lines , 2003 .

[17]  G. Brodeur.  Neuroblastoma: biological insights into a clinical enigma , 2003, Nature Reviews Cancer.

[18]  J. Qin,et al.  Parc A Cytoplasmic Anchor for p53 , 2003, Cell.

[19]  R. Blomhoff,et al.  Gene expression regulation by retinoic acid Published, JLR Papers in Press, August 16, 2002. DOI 10.1194/jlr.R100015-JLR200 , 2002, Journal of Lipid Research.

[20]  K. Nakanishi,et al.  An Endoplasmic Reticulum Stress-specific Caspase Cascade in Apoptosis , 2002, The Journal of Biological Chemistry.

[21]  P. Pérez,et al.  Activation of the Phosphatidylinositol 3-Kinase/Akt Signaling Pathway by Retinoic Acid Is Required for Neural Differentiation of SH-SY5Y Human Neuroblastoma Cells* , 2002, The Journal of Biological Chemistry.

[22]  B. Antonsson.  Bax and other pro-apoptotic Bcl-2 family "killer-proteins" and their victim the mitochondrion , 2001, Cell and Tissue Research.

[23]  C. Reynolds,et al.  Retinoid therapy of childhood cancer. , 2001, Hematology/oncology clinics of North America.

[24]  Andreas Villunger,et al.  Bmf: A Proapoptotic BH3-Only Protein Regulated by Interaction with the Myosin V Actin Motor Complex, Activated by Anoikis , 2001, Science.

[25]  W. Rostène,et al.  Resistance to induced apoptosis in the human neuroblastoma cell line SK-N-SH in relation to neuronal differentiation. Role of Bcl-2 protein family. , 2001, European journal of biochemistry.

[26]  M. Maden.  Role and distribution of retinoic acid during CNS development. , 2001, International review of cytology.

[27]  E. Isogai,et al.  Retinoic acid-induced apoptosis of the CHP134 neuroblastoma cell line is associated with nuclear accumulation of p53 and is rescued by the GDNF/Ret signal. , 2001, Medical and pediatric oncology.

[28]  S. Srinivasula,et al.  Structure-based discovery of an organic compound that binds Bcl-2 protein and induces apoptosis of tumor cells. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[29]  F. Behm,et al.  Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN , 2000, Nature Medicine.

[30]  S. Lippman,et al.  Advances in the development of retinoids as chemopreventive agents. , 2000, The Journal of nutrition.

[31]  Junying Yuan,et al.  Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-β , 2000, Nature.

[32]  K K Matthay,et al.  Treatment of High-Risk Neuroblastoma with Intensive Chemotherapy, Radiotherapy, Autologous Bone Marrow Transplantation, and 13-cis-Retinoic Acid , 1999 .

[33]  M. Iglesias,et al.  Extracellular‐Regulated Kinases and Phosphatidylinositol 3‐Kinase Are Involved in Brain‐Derived Neurotrophic Factor‐Mediated Survival and neuritogenesis of the Neuroblastoma Cell Line SH‐SY5Y , 1999, Journal of neurochemistry.

[34]  D. Roberts,et al.  An institutional review of fulminant hepatic failure in an urban Canadian centre , 1998 .

[35]  U. Moll,et al.  Cytoplasmically sequestered wild-type p53 protein in neuroblastoma is relocated to the nucleus by a C-terminal peptide. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[36]  L. Tsai,et al.  The brain-specific activator p35 allows Cdk5 to escape inhibition by p27Kip1 in neurons. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[37]  K. Matthay,et al.  Phase I trial of 13-cis-retinoic acid in children with neuroblastoma following bone marrow transplantation. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[38]  Genes, chromosomes & cancer , 1995 .

[39]  P. Ramani,et al.  Expression of bcl‐2 gene product in neuroblastoma , 1994, The Journal of pathology.

[40]  A. Nakagawara,et al.  Expression and function of TRK-B and BDNF in human neuroblastomas , 1994, Molecular and cellular biology.

[41]  A. Cantor,et al.  Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma. , 1993, The New England journal of medicine.

[42]  M. Annicchiarico-Petruzzelli,et al.  Phenotype‐specific “tissue” transglutaminase regulation in human neuroblastoma cells in response to retinoic acid: Correlation with cell death by apoptosis , 1992, International journal of cancer.

[43]  A. Nakagawara,et al.  Molecular Basis of Clinical Heterogeneity in Neuroblastoma , 1992, The American journal of pediatric hematology/oncology.

[44]  M. Israel,et al.  Decreased expression of N-myc precedes retinoic acid-induced morphological differentiation of human neuroblastoma , 1985, Nature.